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microRNA-155 (miR-155) is expressed by cells
of the immune system after activation and has
been shown to be required for antibody produc-
tion after vaccination with attenuated Salmo-
nella. Here we show the intrinsic requirement
for miR-155 in B cell responses to thymus-
dependent and -independent antigens. B cells
lacking miR-155 generated reduced extrafollic-
ular and germinal center responses and failed
to produce high-affinity IgG1 antibodies. Gene-
expression profiling of activated B cells indi-
cated that miR-155 regulates an array of genes
with diverse function, many of which are pre-
dicted targets of miR-155. The transcription
factor Pu.1 is validated as a direct target of
miR155-mediated inhibition. When Pu.1 is over-
expressed in wild-type B cells, fewer IgG1 cells
are produced, indicating that loss of Pu.1 regu-
lation is a contributing factor to the miR-155-
deficient phenotype. Our results implicate
post-transcriptional regulation of gene expres-
sion for establishing the terminal differentiation
program of B cells.
INTRODUCTION
microRNAs (miRs) have been shown to regulate gene
expression by sequence-specific base pairing, with target
mRNAs initiating inhibition of translation or degradation of
the mRNA. In animals, miRNAs are transcribed as primary
miRNA (pri-miRNA). The pri-miRNA are processed in the
nucleus to precursor miRNA (pre-miRNA) by the micro-
processor complex prior to their transport into theImcytoplasm. In the cytoplasm, they are further processed
to mature miRNAs by Dicer and incorporated into the
RNA-induced silencing complex (reviewed by Bartel,
2004). T cell-specific deletion of Dicer has revealed
a role for this enzyme in thymic development and the dif-
ferentiation of T lymphocytes (Cobb et al., 2005, 2006;
Muljo et al., 2005; Neilson et al., 2007). Although these
data imply that miRNAs may be important in lymphocyte
development, essential functions for individual miRNAs
have not yet emerged.
miR-155 is contained within the noncoding B cell inte-
gration cluster (Bic) gene (Lagos-Quintana et al., 2002).
Bic was first identified as a frequent site of integration for
the avian leukosis virus, and coexpression of bic with
c-myc has been found to synergize for lymphomageneis
(Tam et al., 1997). In humans, high expression of BIC and
miR-155 has been shown in Hodgkin’s lymphoma, primary
mediastinal B cell lymphoma, and diffuse large B cell lym-
phoma, whereas very low expression of BIC and miR-155
were reported in adult Burkitt lymphoma (Eis et al., 2005;
Metzler et al., 2004; van den Berg et al., 2003). When over-
expressed as a transgene in B cells, miR-155 gives rise to
pre-B cell lymphomas (Costinean et al., 2006). In untrans-
formed cells of the immune system, Bic transcripts and
miR-155 expression appear to be induced by antigenic
stimulation (Haasch et al., 2002; Rodriguez et al., 2007).
Bic is also expressed by macrophages after Toll-like re-
ceptor and type-I interferon stimulation (O’Connell et al.,
2007) and in B cells after treatment with antibodies to
surface IgM (van den Berg et al., 2003). Furthermore,
a subset of human CD20-positive cells within the germinal
center has been shown to express BIC by RNA in situ
hybridization (van den Berg et al., 2003).
Previous studies show that miR-155 mutant mice dis-
play defective B and T cell immunity and abnormal func-
tion of antigen-presenting cells (Rodriguez et al., 2007;
Thai et al., 2007). Moreover, a reduced number of germinal
center B cells was observed in miR-155-deficient mice,munity 27, 847–859, December 2007 ª2007 Elsevier Inc. 847
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miR-155 Regulates B Cell FunctionFigure 1. miR-155-Deficient Mice Produce Reduced Amounts of Low-Affinity IgG1 Antibodies
(A) Wild-type (open squares) or miR-155-deficient chimeric (filled triangles) mice were immunized with DNP-LPS, and anti-DNP-specific antibody
titers were measured 7 days later. *p < 0.05; **p < 0.005 by Student’s t test.
(B and C) Wild-type (open squares) or miR-155-deficient (filled triangles) mice were immunized with NP-KLH in alum at day 0 and day 70, indicated by
the arrowheads. Production of NP-specific antibody titers were measured at the indicated times. Two-way ANOVA was performed and p < 0.0001 for
the genotype and time effect for NP-specific IgG1 antibodies of low and high affinity. Similar experiments were done twice.
(B) Titers of IgM anti-NP were measured with NP17-BSA (left). Titers of IgG1 anti-NP were measured with NP17-BSA (middle) or NP3-BSA (right).
(C) Ratio of the IgG1 titers detected with NP3-BSA to those with NP17-BSA. Each symbol corresponds to one mouse.whereas its overexpression led to the opposite phenotype
(Thai et al., 2007). Neither of these studies identified the
cellular basis of the defects in vivo. Both studies used
miR-155 germline mice, and the conditional expression
of miR-155 was driven by Cre under the control of the
CD21 promoter. Thus, expression of miR155 was targeted
to both B cells and follicular dendritic cells (Victoratos
et al., 2006). Here we show that defects in humoral immu-
nity after primary and secondary immunization are intrinsic
to B lymphocytes. Microarray analysis of B cells activated
under conditions that promote class switching to IgG1
revealed that miR-155 regulates expression of many
genes, a substantial fraction of which are predicted to
be direct targets of miR-155. One of these genes was
Sfpi1 (encoding the transcription factor Pu.1), which has
a highly conserved functional miR-155 binding site in its
30UTR. Moreover, Pu.1 is highly expressed in miR-155-
deficient B cells, and Pu.1 overexpression in wild-type B
cells results in reduced numbers of IgG1-switched cells.
Our results indicate that miR-155 plays a key role in
antigen-driven B cell maturation and the persistence848 Immunity 27, 847–859, December 2007 ª2007 Elsevier Incand/or differentiation of Ig class-switched cells and that
deregulation of Pu.1 is likely to be a contributing factor
to the phenotype observed in miR-155-deficient mice.
RESULTS
Deficiency in miR-155 Leads to Impaired Primary
and Secondary Immune Response
It has been previously shown that miR-155 is dispensable
for lymphocyte development but necessary for the gener-
ation of T and B cell responses in vivo (Rodriguez et al.,
2007; Thai et al., 2007). To further understand the role of
miR-155 in regulating the function of B cells, we studied
the requirement of miR-155 for T-independent type-I
(TI-1) responses by immunizing mice with the dinitrophe-
nylated lypopolysaccharide (DNP-LPS). We observed
defective switched antibody responses at day 7 after
immunization (Figure 1A). By contrast, the production of
antigen-specific IgM was normal.
Next we studied the response of miR-155-deficient
mice to the well-characterized T-dependent (TD) antigen.
Immunity
miR-155 Regulates B Cell FunctionFigure 2. The Deficiency in Switched An-
tibody Production in miR-155-Deficient
Mice Is B Cell Intrinsic
Wild-type (open squares) or miR-155-deficient
(filled triangles) chimeras were immunized with
NP-KLH in alum at day 0.
(A and B) Titers of IgM anti-NP (A) or IgG1 (B)
were measured with NP17-BSA.
(C) Titers of IgG1 anti-NP measured with NP3-
BSA.
(D) Ratio of the IgG1 titers detected with NP3-
BSA to those with NP17-BSA.
(E) Titers of IgG1, IgG2b, and IgG3 anti-NP at
day 14 after immunization. Each symbol corre-
sponds to one mouse.
Statistical analysis: p < 0.0001 for the genotype
and time effect of a two-way ANOVA analysis
for (B)–(D). For (E), the Student’s t test was
used: **p < 0.001. Similar experiments were
done twice.4-hydroxy-3-nitrophenylacetyl conjugated to keyhole lim-
pet hemocyanin (NP-KLH). Wild-type and miR-155-
deficient mice produced similar amounts of NP-specific
antibodies of the IgM class after primary immunization
(Figure 1B, left). On the other hand, the titers of primary
IgG1 antibodies in miR-155 deficient mice were reduced
to 20% of WT controls when NP17-BSA was used as the
capture antigen (Figure 1B, middle). With more stringent
binding conditions with NP3-BSA as the capture antigen,
significant amounts of bound IgG1 were only seen in WT
mice (Figure 1B, right), indicating impaired affinity matura-
tion in the miR-155-deficient mice (Herzenberg et al.,
1980). This defect can be readily seen by calculating the
ratio of titers detected with NP3-BSA to those of NP17-
BSA (Figure 1C). We also observed that reimmunization
with soluble NP-KLH 70 days after primary immunization
yielded impaired memory responses, suggesting that
miR-155 is required for the generation and (or) mainte-
nance or reactivation of memory B cells.
Deficiency in miR-155 Leads to Reduced IgG1
Secretion and Impaired Affinity Maturation in a B
Cell-Autonomous Manner
We wished to determine whether the impaired antibody
production was intrinsic to B cells. To this end, we created
mixed chimeras by transferring 20% of either wild-type or
miR-155-deficient bone-marrow cells with 80% of mMT-
deficient bone-marrow cells into sublethally irradiated
mice double deficient in Rag2 and the common cytokine
receptor gamma chain (Rag2/ Il2rg/ mice), as previ-
ously described (Huntington et al., 2006). The mMT muta-
tion prevents the generation of B cells, so the B cells in theIanimals receiving miR-155-deficient marrow will be
miR-155 deficient, whereas the recipients of wild-type
marrow will have wild-type B cells. The 20/80 ratio favors
reconstitution of all the other hemopoietic lineages from
wild-type precursors (Huntington et al., 2006). Both
groups of chimeras had similar proportions and numbers
of B, CD4+, and CD8+ T cells (data not shown). We first
studied the primary response to NP-KLH and found that
the miR-155-deficient, mMT-deficient chimeras again
had reduced IgG1 antibody production compared to the
WT, mMT-deficient chimeras (Figures 2A–2D) and recapit-
ulated the phenotype observed in miR-155-deficient mice:
specifically, reduced amounts of NP-specific IgG1 in se-
rum and impaired affinity maturation. We also observed
that the defect in Ig secretion was not restricted to IgG1,
because production of IgG2b and IgG3 subclasses was
also significantly reduced (p < 0.001; Figure 2E). These re-
sults demonstrate a B cell-intrinsic requirement miR-155
for the production of switched and high-affinity anti-
bodies.
Impaired Extrafollicular and Germinal Center
Responses in the Absence of miR-155 Lead to
Reduced Numbers of Antigen-Specific IgG1 AFC
The defects observed in the production of antigen-specific
switched antibodies in response to NP-KLH prompted us
to study the primary response by quantitative immunohis-
tology. Immunization with T-dependent (TD) or T-indepen-
dent (TI) antigens elicits an extrafollicular response that
rapidly produces large amounts of IgM and switched anti-
bodies providing a first line of defense. TD antigens, in ad-
dition, promote B cell growth in follicles where they formmmunity 27, 847–859, December 2007 ª2007 Elsevier Inc. 849
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miR-155 Regulates B Cell FunctionFigure 3. Impaired Extrafollicular and Germinal Center Response in the Absence of miR-155
(A) Immunohistochemical analysis of splenic sections from wild-type (WT) or miR-155 chimeric mice showing NP-binding cells (blue) and IgG1-pos-
itive cells (orange) on day 7 after immunization with NP-KLH.
(B) Wild-type (open squares) or miR-155-deficient (filled triangles) chimeras were immunized with NP-KLH. The graph on the left shows the number of
NP-specific extrafollicular plasmacytoid cells per mm2 of spleen section. The graph on the right shows the percentage of splenic section occupied by
germinal centers.
(C) ELISPOT analysis of splenic NP-specific IgG1 AFC (left) or bone-marrow NP-specific IgG1 AFC (right).
(B and C) Each symbol represents one mouse and the horizontal bar corresponds to the media. Statistical analysis was performed by one-way
ANOVA. *p < 0.05; **p < 0.001. In (B), no significance difference (p > 0.05) was observed when comparing miR-155-deficient NP-specific extrafollic-
ular plasmacytoid cells per mm2 at day 0 with day 7 or day 14. Similar experiments were repeated 2–3 times.germinal centers resulting in the production of high-affinity
antibodies by plasma cells and generation of memory B
cells. Examination of naive miR-155-deficient mMT chime-
ric mice reveals no overt abnormality in the structure of the
white pulp (data not shown). However, after immunization
with NP-KLH, the extrafollicular response in miR-155-defi-
cient mMT chimeric mice was severely impaired. This was
reflected by a significant reduction in the number of NP-850 Immunity 27, 847–859, December 2007 ª2007 Elsevier Inspecific plasmacytoid cells (plasmablasts and or plasma
cells) 7 days after immunization (p < 0.05; Figures 3A and
3B). By day 14, the number of NP-specific plasmacytoid
cells had fallen, as expected, in the wild-type chimeric
mice to 10% of their number at day 7. In the miR-155-
deficient mMT chimeric mice, the numbers of NP-specific
plasma cells had fallen to numbers that were not signifi-
cantly different from those in nonimmunized chimerasc.
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NP-specific IgG1 antibody-forming cells (AFC) in the
spleen, measured by enzyme-linked immunosorbent
spot (ELISPOT), mirrored the emergence and disappear-
ance of NP-specific plasmacytoid cells (Figure 3C). More-
over, the frequency of NP-specific IgG1 AFCs was signifi-
cantly reduced in the absence of miR-155 (p < 0.05;
Figure 3C). The average spot size was similar to wild-
type cells (145 ± 24 versus 141 ± 17, n = 4, mean ± SE), sug-
gesting that miR-155 does not regulate secretion from
plasmacytoid cells. Taken together, these results suggest
that miR-155 regulates the output of antibodies produced
in extrafollicular responses.
Analysis of the GC response showed that NP-specific
GC were formed at day 7 in the miR-155-deficient, mMT-
deficient chimeric mice (Figure 3A). However, the areas
occupied by miR-155-deficient GCs were significantly
smaller than those of wild-type mice (p < 0.001; Figures
3A and 3B). Similar results were observed at day 14
(Figure 3B), in agreement with a recent report (Thai
et al., 2007). Antigen-specific plasma cells originating
from the GC reaction preferentially migrate to the bone
marrow where they reside for extended periods. We found
that the frequency of NP-specific IgG1 AFC in the bone
marrow 14 days after immunization was significantly
reduced in the chimeric mice with miR-155-deficient B
cells compared to those with WT B cells (p < 0.05;
Figure 3C). Reduced switched antibody production by
miR-155-deficient B cells is therefore a consequence of
lowered numbers of switched plasma cells arising from
the extrafollicular and the GC responses.
Impaired Memory Response in the Absence
of miR-155 Is B Cell Autonomous
Secondary immunization of miR-155-deficient germline
mice yielded reduced production of antigen-specific anti-
bodies of low affinity (Figures 1B–1E). To assess intrinsic
defects of miR-155-deficient memory B cells, we used
the adoptive transfer method, because B cells influence
T helper cell function and T cell memory (Linton et al.,
2000, 2003; van Essen et al., 2000) and T cells, in turn, in-
fluence B cell memory function. B220+ cells were purified
from the spleens of WT, mMT chimeric or miR-155-defi-
cient mMT chimeras previously immunized with NP-KLH
in alum and mixed with KLH-primed T cells from C57BL/
6 mice. The mixed cells were then transferred into
Rag2/ Il2rg/ double-deficient mice and boosted
with soluble NP-KLH. The titers of anti-NP IgG1 antibodies
were below detection when the mice were not immunized,
suggesting no contamination by long-lived AFC in trans-
ferred B cells (Figure 4). Also, NP-IgG1 titers from mice
that received T cells only were below the limit of detection,
suggesting no contamination with wild-type antigen-
specific B cells (Figure 4). As observed in the primary
response, we found reduced amounts of NP-specific
IgG1 antibodies (Figures 4A and 4B) and impaired affinity
maturation (Figure 4D). Thus, memory B cell function is
regulated by miR-155 in a B cell-autonomous manner.
To assess whether miR-155 is required for the generationImand/or maintenance of memory B cells, we identified by
FACS antigen-specific switched memory B cells 42 days
after immunization with NP-KLH. At this time point, a sta-
ble population of IgG1+, NP+, B220+ is found in the spleen
(Blink et al., 2005). We observed a reduced proportion of
switched memory cells in the absence of miR-155
(Figure 4E), suggesting that miR-155 may regulate the
generation or maintenance of memory B cells.
Normal Rate of Somatic Hypermutation and Class
Switch Recombination in miR-155-Deficient B
Cells
Impaired production of high-affinity antibodies and re-
duced amounts of switched antibodies can result from
dysfunction of the machinery for somatic hypermutation
(SHM) and class switch recombination (CSR). To assess
whether miR-155 was required for somatic hypermuta-
tion, we compared the frequency and pattern of mutations
between wild-type and miR-155/ mice in a system that
is not biased by selection. This was achieved by sequenc-
ing the intronic VHJ558-JH rearrangement-flanking re-
gions from germinal center B cells obtained from Peyer’s
patches (Jolly et al., 1997). Our analysis showed no signif-
icant difference in the frequency of mutations between
wild-type and miR-155-deficient B cells (p = 0.4; Fig-
ure 5A). Moreover, no difference in the pattern of nucleo-
tide substitutions was observed between wild-type and
miR-155-deficient B cells (Figure 5A). We conclude that
miR-155 does not regulate the machinery for SHM.
To examine CSR to IgG1, we used the well-character-
ized in vitro system of culturing B cells with LPS and IL-4
(Hodgkin et al., 1996). After culture with LPS and IL-4,
miR-155-deficient B cells produced reduced IgG1 (Rodri-
guez et al., 2007). Defective secretion of IgG1 was
accompanied by a reduction in the proportion of cells ex-
pressing IgG1 on the cell surface (Figure S1 in the Supple-
mental Data available online). Combinations of CD40 with
IL-4 or IL-5 yielded similar results (Figure S1B). By con-
trast, the number of CD138-positive cells was only margin-
ally impaired, consistent with normal IgM secretion
(Figure S1B). This inhibition was not reflected in a failure
of B cells to proliferate, as judged by incorporation of radio-
active thymidine with a variety of stimuli (Rodriguez et al.,
2007; also Figure S1A). We next quantified the expression
of activation-induced cytidine deaminase (Aicda) mRNA,
because this enzyme regulates CSR, but we found this
was not reduced in the absence of miR-155 (Figure 5B).
We also found similar expression of m and g1 encoding
sterile transcripts as well asg1 encoding post-switch circle
transcripts in miR-155-deficient and wild-type B cells
(Figure 5C). Thus, the failure of miR-155-deficient B cells
to generate high-affinity switched antibodies appears not
to be due to a defect in SHM or CSR but more likely to a de-
fect in the differentiation or survival of plasmablasts.
We examined whether the reduction in the number of
IgG1+ cells after in vitro differentiation of miR-155-defi-
cient B cells with LPS and IL-4 reflected defective survival.
bcl-2 promotes survival of lymphocytes both in vivo and
in vitro (Vaux, 1993), so we tested whether the numbermunity 27, 847–859, December 2007 ª2007 Elsevier Inc. 851
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miR-155 Regulates B Cell FunctionFigure 4. The Defective Memory Response in miR-155-Deficient Mice Is B Cell Intrinsic
NP-primed B cells from wild-type (WT) or miR-155-deficient (miR-155) chimeras were mixed with wild-type carrier-primed T cells and transferred into
Rag2/ Il2rg/ mice. Subsequently, recipient mice were immunized with soluble NP-KLH, and 1 week later, antigen-specific IgM and IgG1 were
measured. Control groups are indicated.
(A and B) Titers of IgG1 anti-NP measured with NP17-BSA (A) or NP3-BSA (B).
(C) Titers of IgM anti-NP with NP17-BSA.
(D) Ratio of the IgG1 titers detected with NP3-BSA to those with NP17-BSA. Each symbol represents an individual mouse and horizontal bars indicate
the average. The indicated p values were calculated by Student’s t test.
(E) Frequency of memory B cells after 42 days of immunization with NP-KLH. Red blood cell-depleted splenic cells were gated as B220+, CD4, CD8,
IgM, IgD, Gr-1, F4/80, PI, and analyzed for the expression of NP and IgG1. Dot plots correspond to a representative example of a mouse of each
genotype. The top panel corresponds to nonimmunized mice, the bottom panel to NP-KLH-immunized mice. The boxes indicate the frequency of
NP+, IgG1+ cells. The graph summarizes the results of four mice of each genotype: open squares correspond to wild-type, filled triangles to
miR-155-deficient mice. A significance reduction in the proportion of NP+IgG1+ cells after immunization was observed in the absence of miR-155
(p = 0.03, by Student’s t test).of IgG1+ cells could be rescued by exogenous expression
of bcl-2. To this end, miR-155-deficient B cells were trans-
duced with a retrovirus expressing bcl-2 with an IRES-
GFP reporter to enable the identification of infected cells.
The results indicate that bcl-2 was unable to rescue the
defect (Figure S2).
Genome-wide Analysis of Gene Expression Shows
Enrichment of miR-155 Binding Sites in mRNA
Upregulated inmiR-155/ B Cells
Our results thus far indicate that miR-155 is required for
the maintenance and/or differentiation of IgG-switched
cells. To analyze how the absence of miR-155 affects
the global gene-expression program underlying B cell dif-
ferentiation, we compared gene expression in wild-type852 Immunity 27, 847–859, December 2007 ª2007 Elsevier Inand miR-155-deficient B cells treated with LPS and IL-4.
Kinetic analysis indicates that Bic and miR-155 expres-
sion peaks at 24 hr after stimulation with LPS and IL-4
(Figure S3). This time point was chosen because it allows
the examination of gene expression before the emergence
of IgG1 cells. Because direct targets are predicted to have
higher expression in absence of miR-155, we expected
them to be enriched among the genes upregulated in
miR-155-deficient B cells.
A total of 101 protein coding genes were significantly
increased in miR-155-deficient B cells whereas 84 were
decreased in expression (p < 0.05). Among the deregu-
lated genes are transcription factors, signaling molecules,
adhesion molecules, and regulators of chemotaxis (Tables
S1 and S2). Several groups have computationallyc.
Immunity
miR-155 Regulates B Cell FunctionFigure 5. Hypermutation in miR-155-Deficient B Cells in Peyer’s Patch GC Despite Impaired IgG1 Secretion
(A) Analysis of mutations in the intronic VHJ558-JH rearrangement-flanking region of wild-type and miR-155-deficient germinal center B cells purified
from Peyer’s Patches. Segment sizes in the pie charts are proportional to the number of sequences carrying the number of mutations indicated in the
periphery of the charts. The total number of sequences analyzed is indicated in the center of the chart. The frequency of mutations is expressed as
the mean ± SD for 3 mice per group, and the p value was calculated by Student’s t test. The tables indicate the percentage nucleotide substitution.
The total number of mutations was 275 for the wild-type and 196 for the miR-155-deficient mice.
(B and C) Splenic B cells were cultured with LPS+IL-4 for 3 days. Each symbol corresponds to B cells isolated from an individual mouse, the horizontal
bar indicates the average, open squares correspond to wild-type B cells, and filled triangles to miR-155-deficient cells.
(B) Induction of Aicda.
(C) Expression of m encoding sterile transcripts (left), g1 encoding sterile transcripts (middle), and post-switch encoding g1 circular transcripts (right).
This experiment was repeated 2–3 times.predicted miRNA targets based on perfect Watson-Crick
complementarity of 6–8 nucleotides between the 50 end
of a miRNA and the 30UTR of mRNAs (Brennecke et al.,
2005; Doench and Sharp, 2004; Lai, 2002), a region of
the miRNA referred to as the ‘‘seed.’’ To test whether up-
regulated mRNAs in miR-155-deficient B cells may be di-
rect miR-155 targets, we searched their 30UTR for the
presence of miR-155 seed matches. We found 97 upregu-
lated transcripts with annotated 30UTRs, 60 of which con-
tain at least one seed match for miR-155 (Figure 6A; Table
S2). As a control, we searched the upregulated gene set for
seed matches for all mouse miRNAs present in miRBase
9.1 (Giraldez et al., 2006; Griffiths-Jones et al., 2006).
Among all possible 6nt, 7nt, and 8nt seed sequences,
only the enrichment of miR-155 matches was found to beImstatistically significant (p = 4.3 3 105, Figure 6B; Experi-
mental Procedures). When performing a similar analysis
with all possible hexamers, the miR-155 6nt seed was
found to be the top-ranked hexamer (data not shown).
These results demonstrate a highly significant enrichment
of direct miR-155 targets among the mRNAs that were
increased in abundance in miR-155-deficient B cells.
Pu.1 Is a Direct Target of miR-155, and Its
Overexpression in Wild-Type B Cells Impairs
the Emergence of IgG1-Switched Cells
Computationally predicted targets for miR-155 include
transcription factors and regulators of cell differentiation
and metabolism. Expression of Aicda was 1.6-fold in-
creased in miR-155-deficient B cells (Table S2), a trendmunity 27, 847–859, December 2007 ª2007 Elsevier Inc. 853
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miR-155 Regulates B Cell FunctionFigure 6. Enrichment for miR-155 Seeds in Genes Upregulated in miR155-Deficient B Cells
(A) Representation of miR-155 ‘‘seeds’’ in the group of upregulated genes in miR-155-deficient B cells. Genes were grouped according to their
content of 6 nt seeds, 7 nt(1), 7 nt(2), or 8 nt miR-155 seeds and represented in a pie chart.
(B) Enrichment for 6 nt seeds, 7 nt(1), 7 nt(2), or 8 nt miR-155 seeds.
(C) Enrichment of mouse 50miRNA seed sequences contained in the 30UTRs of significantly upregulated genes. The p value for miR-155 is indicated.we have also observed after 72 hr of in vitro culture with
LPS and IL-4 (Figure 5B). We further validated the expres-
sion of five other genes upregulated in miR155-deficient B
cells that contain miR-155 binding sites in their 30UTRs, by
quantitative PCR (Figure 7A). We focused our attention on
Sfpi1, the gene encoding Pu.1, a member of the Ets do-
main-transcription factor family that plays a central role
in many aspects of hematopoiesis. In B cells, Pu.1 is re-
quired at early developmental stages (McKercher et al.,
1996; Scott et al., 1994) and has overlapping roles, in
the regulation of B cell function, with another Ets family
member SpiB (Garrett-Sinha et al., 1999). Pu.1 is ex-
pressed at low amounts in lymphocytes and was not read-854 Immunity 27, 847–859, December 2007 ª2007 Elsevier Incily detected by immunoblot of lysates from wild-type B
cells. However, we could easily detect Pu.1 expressed in
miR-155-deficient B cells (Figure 7B), consistent with
Pu.1 being a direct target of miR-155. The 30UTR of Pu.1
includes a phylogenetically conserved stretch of eight
nucleotides perfectly complementary to the miR-155
seed region (Figure 7C, left). When the Pu.1 30UTR was
coupled to a luciferase reporter and cotransfected with
miR155 mimics into 293T cells, we observed significant
repression of the reporter (p < 0.0001; Figure 7C, right).
The repression was alleviated when three nucleotides
from the predicted binding site were mutated (Figure 7C,
right), indicating that this binding site is functional. Taken.
Immunity
miR-155 Regulates B Cell Functiontogether, these results indicate that Pu.1 is a direct target
of miR155. We next tested whether overexpression of
Pu.1 recapitulated aspects of the phenotype caused by
deletion of miR-155. To this end, we transduced wild-
type B cells stimulated with LPS+IL-4 with a retroviral vec-
tor allowing bicistronic expression of Pu.1 and GFP. After
3 days, surface expression of IgG1 was determined in the
fraction of B cells expressing Pu.1, which were identified
on the basis of being GFP+. We observed a reduction in
the proportion of IgG1-expressing cells (Figure 7D), which
resembled the in vitro phenotype of miR-155-deficient B
cells (Figure S2). Similar results were observed when we
measured intracellular expression of IgG1 (Figure 7E,
left). The proportion of IgM-positive cells was accordingly
increased when Pu.1 was overexpressed (Figure 7E,
right). As with miR-155-deficient cells, the inability to
switch was not due to altered cell division. Staining with
the dye PKH26, which allowed tracking of cell divisions
by GFP-expressing cells, showed a similar extent of divi-
sion between wild-type cells transduced with GPF only
expressing virus or GFP and Pu.1 (Figure 7F). The switch-
ing was specific to Pu.1, as shown by the fact that overex-
pression of another predicted target of miR-155, c-myb,
resulted in impaired cell survival (data not shown). Taken
together, our results suggest that miR-155 may affect
the generation of IgG1+ cells in vitro by regulating the
expression of Pu.1.
DISCUSSION
Here we demonstrate that miR-155 is required for TI and
TD responses, particularly the production of switched an-
tibodies. Chimeric mice recapitulated all of the phenotypic
alterations observed in the germline mice, and therefore B
cells require miR-155 function in a cell-autonomous man-
ner for the secretion of switched antibodies and affinity
maturation in both primary and memory responses.
Our analysis of the primary TD response indicated the
extrafollicular response was suppressed in miR-155-defi-
cient B cells. This reduction was not due to defective pro-
liferation, nor to reduced frequency of NP-binding B cell
precursors (data not shown). In addition, we found re-
duced humoral responses after immunization with the TI
antigens DNP-LPS and DNP-Ficoll (data not shown), two
antigens that promote a robust extrafollicular response.
It is thus possible that NP-specific cells are being recruited
into the response, but miR-155 deficiency prevents most
of these cells maturing into plasmablasts. Alternatively,
there may be a high death rate among miR-155-deficient
plasmablasts. In contrast to our current study, where im-
munization with haptenated proteins leads to normal
IgM responses, infection of miR-155-deficient mice with
attenuated Salmonella resulted in reduced secretion of
antigen-specific IgM (Rodriguez et al., 2007). This differ-
ence may be due to the different responses these antigens
elicit. Unlike NP-KLH, infection with Salmonella generates
a massive T-dependent extrafollicular response that per-
sists for up to 5 weeks (Cunningham et al., 2007). Further-
more, it is possible that reduction of IgM in the SalmonellaIminfection is not B cell autonomous, because the experi-
ment has been conducted only in germline mice.
The kinetics of formation of GCs was not affected by
miR-155 deletion, despite a 50%–60% reduction in the
size of the GCs. We found a 50% reduction in the propor-
tion of GC B cells from Peyer’s patches of miR-155-defi-
cient mice (data not shown). The outcome of the GC
response was also impaired, as shown by the fact that
there were reduced numbers of antigen-specific IgG1
plasma cells within the bone marrow and impaired pro-
duction of high-affinity antibody. The secondary IgM re-
sponse of germline mice was defective, suggesting that
low-affinity memory responses were impaired. Taken to-
gether, these data indicate that miR-155 may regulate
the emergence or maintenance of memory cells.
SHM and CSR operate normally in the absence of
miR-155, and therefore we suggest that miR-155-defi-
cient B cells are likely able to class switch and hypermu-
tate in vivo. The loss of affinity maturation in the presence
of hypermutation suggests that there is a failure to select
high-affinity B cells. This might reflect impaired signaling
through the BCR or other receptors during selection and
may partly explain the reduction in size of the GCs. In sup-
port of that, BIC is expressed upon BCR crosslinking (van
den Berg et al., 2003), by a subset of germinal center B
cells (van den Berg et al., 2003), and, in mice, upon
CD40 stimulation (data not shown). Some limited selection
must be occurring, because GC in the chimeras with miR-
155-deficient B cells were small but persistent. Overex-
pression of bcl-2 can prolong survival but cannot provide
differentiation signals. Thus, in vivo miR-155-deficient B
cells may be receiving sufficient selection signals to sur-
vive, but still may be failing to receive, or respond to, sig-
nals that induce differentiation to plasma cells. Another
contributing factor to the defective germinal center re-
sponse in miR-155 may be reduced production of cyto-
kines by B cells, as has been previously suggested (Thai
et al., 2007). However, our histological analysis showed
that the anatomy of the germinal centers (dark and light
zones) was not affected by the absence of miR-155 in B
cells (data not shown).
Our current model of plasma cell differentiation is based
on the concerted action of several transcription factors
(reviewed by Shapiro-Shelef and Calame, 2005). Our re-
sults show that miR-155 directly regulates the expression
of Pu.1, and its overexpression impairs the emergence of
IgG1-positive cells. It is currently unknown how Pu.1 may
regulate terminal B cell differentiation, because no pheno-
type was observed in mice with B cells deficient in Pu.1
(Polli et al., 2005). It is worth noting that Pu.1 is highly
expressed in germinal center B cells and is downregulated
in post-germinal center cells (Cattoretti et al., 2006).
Therefore, it is possible that miR-155 is required for the
downregulation of Pu.1, and, in the absence of miR-155,
excessive Pu.1 affects the output of the germinal center
reaction.
Microarray analysis showed that deletion of a single
miRNA in B cells causes deregulation of a large num-
ber of genes. Among genes that showed increasedmunity 27, 847–859, December 2007 ª2007 Elsevier Inc. 855
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miR-155 Regulates B Cell FunctionFigure 7. Pu.1 Is a Direct Target of miR155 and Its Overexpression in Wild-Type B Cells Results in a Reduction of IgG1-Switched
Cells
(A) Expression of Sfpi1, Myb, Rheb, Bat5, and Jarid2 was assessed by q-PCR. Data are represented as the increase in miR-155 relative to wild-type
amounts set at 1 (n = 4). Error bars correspond to the standard error of the mean. For all genes, p% 0.05.
(B) Protein expression of Pu.1 from B cell cultures from 3 wild-type and 3 miR-155-deficient mice.
(C) Left panel, sequence alignment of part of the 30UTR of PU.1 from different species. The 8 ntmiR155 binding site is boxed. The AAU sequence
indicated below the alignment shows the mutagen derivative created to assess miR-155-dependent translational repression in the luciferase reporter
assay. Wild-type (WT) or mutant Pu.1 (mutant) plasmid were cotransfected with miR-155 mimic (closed bars) or control miR-124a (open bars). The
right panel shows a significant miR-155-specific repression of Pu.1 reporter. Results are presented as mean ± standard error of the mean for triplicate
transfections. *p < 0.0001 in comparison with wild-type plasmid treated control mimic by Student’s t test.856 Immunity 27, 847–859, December 2007 ª2007 Elsevier Inc.
Immunity
miR-155 Regulates B Cell Functionexpression, more than half of them were predicted to be
direct targets of miR-155. It is thus possible that the phe-
notypic alterations observed in miR-155-deficient mice
are the result of deregulation of other targets in addition
to Pu.1. Such a view is consistent with recent reports of
the role of miR-181a in setting the threshold for T cell re-
ceptor signal transduction through the regulation of multi-
ple phosphatases (Li et al., 2007) or in the regulation of
cardiogenesis by miRNA-1-2 (Zhao et al., 2007). Elucidat-
ing how deregulation of Pu.1 contributes to the phenotype
caused by deletion of miR-155 in vivo will be the next chal-
lenge.
EXPERIMENTAL PROCEDURES
Generation of Chimeric Mice and Immunization
miR-155-deficient mice (Bicm2 allele) were previously described (Ro-
driguez et al., 2007). For TI responses, Rag2/ Il2rg/ mice were
irradiated (5.0 Gy) and reconstituted with 3 3 106 bone-marrow cells.
For the generation of mixed chimeras, irradiated Rag2/ Il2rg/ mice
received a mixture of 80% bone-marrow cells of mMT origin and 20%
wild-type or miR-155-deficient cells. For TI responses, 25 mg of
DNP-LPS was administered intraperitoneally. For TD responses,
100 mg of alum-precipitated NP-KLH (Biosearch Tech) was used.
Adoptive Transfer and Immunization
Splenic B cells were enriched by positive selection with B220 beads
(Miltenyi Biotech) from either WT, mMT chimeras or miR-155-deficient
mMT chimeras previously immunized with 100 mg of NP-KLH precipi-
tated in alum. T cells were enriched by negative selection by MACS
system (Miltenyi Biotech) from the spleens of C57BL/6 immunized
with NP-KLH in alum. The mixture of separated B cells (5 3 106) and
T cells (2.03 106) were i.v. injected intoRag2/ Il2rg/ mice and sub-
sequently immunized with 50 mg of soluble NP-KLH.
ELISA and ELISPOT Assay
NP-specific AFC were detected with ELISPOT as previously described
(Xiang et al., 2007). NP-specific antibodies were detected by ELISA as
previously described, except that antibody end point titers were used
as a measure of relative concentration.
Immunohistology
NP, IgG1 staining were detected as described previously (Cunning-
ham et al., 2002; Luther et al., 1997). NP-binding cells were detected
with NP conjugated to sheep IgG fraction. Biotinylated donkey anti-
goat-Ig antibodies (Dako), which bind sheep Ig, were used as a conju-
gate to detect bound NP–sheep-Ig (Luther et al., 1997). The proportion
of spleen sections occupied by germinal sections was determined by
the point counting technique of Weible (Weibel, 1963). NP-specific
plasmacytoid cells per mm2 were counted at 3100 magnification
with serial sweeps of each spleen section by means of a 1 cm2 eye-
piece graticule divided into 100 one mm2 squares to define the section
area being counted.
B Cell Stimulation and Quantitative PCR
B cells were purified by negative selection with the MACS system
(Miltenyi Biotech) and stimulated with 10 mg/ml LPS (Sigma) andI20 ng/ml IL-4 (Peprotech) for 3 days. Subsequently, RNA was ex-
tracted with TRIzol (Invitrogen) and converted to cDNA. Controls with-
out reverse transcriptase were included for all samples. Aicda, Sfpi1,
Myb, Bat5, Rheb, Jarid2 mRNA, and Bic mRNA were quantified with
Taqman probes (Applied Biosystems) and normalized to the expres-
sion of b2M (Applied Biosystems). Expression of m and g1 encoding
sterile transcripts and post-switch g1 encoding circular transcripts
were normalized with GADPH exactly as described (Reina-San-Martin
et al., 2003).
SHM
Germinal center B cells were identified as and purified by FACS sort-
ing. We analyzed somatic hypermutation by monitoring mutations in
the intronic VHJ558-JH rearrangement-flanking region in germinal cen-
ter B cells purified from Peyer’s patches as described (Jolly et al.,
1997). GC B cells were identified as B220+CD95+ PNAhigh and purified
by FACS sort from 4-month-old mice (C57BL/6).
Microarray Analysis
B cells from five wild-type and five miR-155-deficient mice were cul-
tured with LPS and IL-4 for 24 hr as described above, and RNA was
extracted with TRIzol. Gene-expression profiling was performed by
hybridization to the mouse genome 430 2.0 Genechip arrays (Affyme-
trix) by Geneservice Ltd (Cambridge, UK). Genes with p < 0.05 and
a fold expression differenceRj1.5j were selected for further analysis.
Computational miRNA Target Search and Calculation
of Binding Site Frequencies in Mouse 30UTRs
The method used to calculate miRNA binding site frequencies was
essentially as described (Giraldez et al., 2006). Mouse miRNAs in miR-
base registry Release 9.1 (Griffiths-Jones, 2004) were included in our
analysis. The set of upregulated transcripts for which 30UTR se-
quences could be obtained (test group) were examined for potential
miRNA ‘‘seed’’ matches. The average number of seed sequences
found in the test group per 1 kb of sequence was used to calculate
seed ‘‘Observed Frequency’’ (F_obs) values. The seed ‘‘Genome Fre-
quency’’ (F_genome) values were calculated from all mouse 30UTRs
present on the microarray and represent the average occurrence for
any given seed sequence pattern per 1 kb of sequence. The ‘‘Fold
Enrichment’’ (FE) value is calculated as: FE = log(F_obs/F_genome).
To correct for low-count biases, those miRNAs whose 6nt(2) seed
was present at less than 0.1 sites/kb in genomic 30UTRs were removed
from the analysis. To calculate the statistical significance of the FE for
any seed, we randomly selected 10,000 sets with the same number of
30UTR as the test group. From each one of these, FE_rand values were
calculated and the mean and standard deviation (SD) were obtained.
We can then describe any seed FE with a Z score = (FE – mean)/SD.
These Z-scores are essentially ‘‘Fold Enrichment’’ scores that have
been normalized, taking into account the enrichment variability of
that particular seed in the genome. A p value was calculated for
each Z score as well as an E value that takes into account the multiple
numbers of seeds that we are testing.
Luciferase Assays
The Sfpi1 30UTR was amplified from genomic DNA and inserted into
the psiCheck-2 renilla luciferase reporter plasmid (Promega). This con-
struct was used to derive a miR-155 ‘‘seed’’ mutant plasmid with the
QuikChange Multi Site Mutagenesis Kit (Stratagene). The mutagenic
primers used were sense, 50-gaccccgccggccatagcaaatacccgtcgcc-
30, and antisense, 50-ggcgacgggtatttgctatggccggcggggtc-30. The(D–F) Wild-type or miR-155-deficient B cells were cultured in the presence of LPS and IL-4. After 16 hr, cells were transduced with retrovirus
expressing GFP or GFP and Pu.1 and cultured for 3 more days.
(D) Cultures were then stained for surface IgG1 expression. The left panel shows a representative example of cultures from one mouse transduced
with each virus. The graph summarizes the results observed for cultures arising from four mice.
(E) Same as (D) except cells were stained for intracellular IgG1 (icIgG1) expression (left) or surface IgM (sIgM, right).
(F) Before culture, B cells were stained with PKH26 to follow proliferation. Representative histograms gated on GFP+ cells for B cells transduced with
GFP virus (black line) or GFP-Pu.1 (dashed line) are shown. This experiment was repeated 2–4 times.mmunity 27, 847–859, December 2007 ª2007 Elsevier Inc. 857
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assays were performed in 293T cells cotransfected in triplicates with
Lipofectamine 2000 (Invitrogen) with test plasmid (30UTR Pu.1 wild-
type or mutant) along with either murine miR-155 mimic or miR-124a
control (Dharmacon) at a final concentration of 40 nM. Firefly luciferase
was used as a normalization control. Reporter activity was detected 24
hr after transfection with the Dual-Glo Luciferase Assay System (Prom-
ega). Expression values were normalized against the average value for
the corresponding plasmid as in Rodriguez et al. (2007).
Retroviral Infection and FACS Analysis
Stable cell lines with bicistronic expression of bcl-2 and GFP or GFP
alone were kindly provided by D. Wang (Wen et al., 2003). Retroviral
control and GFP/Pu.1-expressing vectors were kindly provided by R.
DeKoter (DeKoter and Singh, 2000). In this case, viral supernatants
were collected 48 hr after transiently transfecting PlatE cells. Purified
B cells were cultured with LPS and IL-4 as described above. After 16
hr, cell supernatant was removed and cells were resuspended in viral
supernatant supplemented with 6 mg/ml of polybrene, LPS, and IL-4
and centrifuged for 30 min at 2500 rpm at room temperature. Cells
were returned to 37C, and the following day, supernatant was re-
moved and cells were recultured in LPS and IL-4 until analyzed by
FACS. Cultured cells were stained with the following antibodies:
anti-Syndecan 1 (CD138), 281.2 (BD); anti-IgG1, A85-1; and anti-
IgM, goat polyclonal (Jackson Laboratories). For intracellular staining,
cells were fixed for 20 min with Cytofix-cytoperm (BD) and stained in
Perm-wash solution (BD). Data were collected with FACscaliber or
LSRII (BD) and analyzed with Flowjo (treestar).
Proliferation
The following B cell stimuli were used at the indicated concentrations:
anti-IgM F(ab)2 fragment, 5 mg/ml; anti-CD40 (3/23 clone), 10 mg/ml;
mIL-4 (Peprotech), 20 ng/ml; mIL-5 (Sigma), 25 ng/ml. B cell prolifera-
tion was measured after addition of [3H]thymidine for the final 16 hr of
culture.
Bic and miR-155 Expression
Expression ofBicwas measured by quantitative PCR as previously de-
scribed (Rodriguez et al., 2007). miR-155 expression was determined
by northern blot as previously described (Rodriguez et al., 2007).
Statistical Analysis
Statistical analysis was performed with two-tailed Student’s t test or
one-way or two-ways ANOVA, as indicated in the figures legends,
with GraphPad Prism 4 or Graphpad InStat 3 software.
Supplemental Data
Three figures and two tables are available at http://www.immunity.
com/cgi/content/full/27/6/847/DC1/.
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